Literature DB >> 27194254

The learning curve of laparoendoscopic single-site adrenalectomy: an analysis of over 100 cases.

Keishiro Fukumoto1, Akira Miyajima2, Seiya Hattori1, Kazuhiro Matsumoto1, Takayuki Abe3,4, Isao Kurihara5, Masahiro Jinzaki6, Eiji Kikuchi1, Mototsugu Oya1.   

Abstract

BACKGROUND: Recently, laparoendoscopic single-site adrenalectomy (LESS-A) has been developed as an alternative treatment for adrenal tumors. Although LESS-A is more technically complex than conventional laparoscopic adrenalectomy, its learning curve and the factors associated with poor surgical outcomes are poorly understood. We analyzed the learning curve of LESS-A and attempted to identify risk factors associated with worse surgical outcomes.
METHODS: We identified 103 patients who underwent LESS-A [performed by the same surgeon (A.M.)] from 2009 to 2015. The learning curve was analyzed using the moving average method (the 10-case moving average), and we assessed potential risk factors for a prolonged pneumoperitoneum time.
RESULTS: The learning curve stabilized at 30 cases. The cases were divided into two groups, the learning stage (LS) (cases 1-29) and master stage (MS) (cases 30-103) groups. The percentage of females and the frequency of previous abdominal surgery were higher in the LS group (p = 0.022 and 0.001, respectively). In the LS group, the mean pneumoperitoneum time was 92 ± 35 min, which was significantly longer than the equivalent value for the MS group (55 ± 18 min, p < 0.001). In the LS group, univariate analysis revealed that tumor size (≥50 mm) and the visceral fat area (VFA)/total fat area (TFA) ratio (≥0.49) were significantly associated with a prolonged pneumoperitoneum time (p = 0.046 and 0.046, respectively). In the multivariate analysis, tumor size and the VFA/TFA ratio were confirmed to be associated with a prolonged pneumoperitoneum time (p = 0.029 and 0.029, odds ratio 20.83 and 20.83, respectively). On the other hand, none of the examined factors were found to be associated with a prolonged pneumoperitoneum time in the MS group.
CONCLUSIONS: LESS-A was performed safely in most cases. However, surgeons who are learning the LESS-A procedure need to pay attention to tumor size and visceral obesity.

Entities:  

Keywords:  Laparoendoscopic single-site adrenalectomy; Laparoendoscopic single-site surgery; Learning curve; Surgical outcome

Mesh:

Year:  2016        PMID: 27194254     DOI: 10.1007/s00464-016-4950-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  21 in total

1.  Transumbilical approach for laparo-endoscopic single-site adrenalectomy: initial experience and short-term outcome.

Authors:  Akira Miyajima; Seiya Hattori; Takahiro Maeda; Masanori Hasegawa; Toshikazu Takeda; Eiji Kikuchi; Hiroshi Asanuma; Ken Nakagawa; Mototsugu Oya
Journal:  Int J Urol       Date:  2011-12-14       Impact factor: 3.369

2.  Visceral fat is correlated with prolonged operative time in laparoendoscopic single-site adrenalectomy and laparoscopic adrenalectomy.

Authors:  Masanori Hasegawa; Akira Miyajima; Masahiro Jinzaki; Takahiro Maeda; Toshikazu Takeda; Eiji Kikuchi; Hirotaka Shibata; Mototsugu Oya
Journal:  Urology       Date:  2013-10-16       Impact factor: 2.649

3.  Single-incision laparoscopic adrenalectomy.

Authors:  Fatih Tunca; Yasemin Giles Senyurek; Tarik Terzioglu; Yalın Iscan; Serdar Tezelman
Journal:  Surg Endosc       Date:  2011-07-15       Impact factor: 4.584

4.  Laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: a comparison of surgical outcomes and an analysis of a single surgeon's learning curve.

Authors:  Yosuke Hirasawa; Akira Miyajima; Seiya Hattori; Kazutoshi Miyashita; Isao Kurihara; Hirotaka Shibata; Eiji Kikuchi; Ken Nakagawa; Mototsugu Oya
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

5.  Adipose tissue volume determination in males by computed tomography and 40K.

Authors:  H Kvist; B Chowdhury; L Sjöström; U Tylén; A Cederblad
Journal:  Int J Obes       Date:  1988

6.  Single-incision transperitoneal laparoscopic left adrenalectomy.

Authors:  Óscar Vidal; Emiliano Astudillo; Mauro Valentini; Cesar Ginestà; Juan C García-Valdecasas; Laureano Fernandez-Cruz
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

7.  A comparative study of multiport versus laparoendoscopic single-site adrenalectomy for benign adrenal tumors.

Authors:  Victor Chia-Hsiang Lin; Yao-Chou Tsai; Shiu-Dong Chung; Tin Chou Li; Chen-Hsun Ho; Fu-Shan Jaw; Huai-Ching Tai; Hong-Jeng Yu
Journal:  Surg Endosc       Date:  2011-11-15       Impact factor: 4.584

8.  Laparoendoscopic single-site and conventional laparoscopic adrenalectomy: a matched case-control study.

Authors:  Byong Chang Jeong; Yong Hyun Park; Deok Hyun Han; Hyeon Hoe Kim
Journal:  J Endourol       Date:  2009-12       Impact factor: 2.942

9.  Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma.

Authors:  Seiya Hattori; Akira Miyajima; Yousuke Hirasawa; Eiji Kikuchi; Isao Kurihara; Kazutoshi Miyashita; Hirotaka Shibata; Ken Nakagawa; Mototsugu Oya
Journal:  J Endourol       Date:  2014-03-24       Impact factor: 2.942

10.  Laparoendoscopic single-site retroperitoneoscopic adrenalectomy: a matched-pair comparison with the gold standard.

Authors:  Tao-ping Shi; Xu Zhang; Xin Ma; Hong-zhao Li; Jie Zhu; Bao-jun Wang; Jiang-ping Gao; Wei Cai; Juan Dong
Journal:  Surg Endosc       Date:  2010-12-18       Impact factor: 4.584

View more
  2 in total

Review 1.  Training in endocrine surgery.

Authors:  Oliver Gimm; Marcin Barczyński; Radu Mihai; Marco Raffaelli
Journal:  Langenbecks Arch Surg       Date:  2019-11-07       Impact factor: 3.445

Review 2.  Laparoendoscopic single-site adrenalectomy versus multi-port laparoendoscopic adrenalectomy: A systemic review and meta-analysis.

Authors:  Jeng-Cheng Wu; Po-Chien Wu; Yi-No Kang; Ting-En Tai
Journal:  Ann Med Surg (Lond)       Date:  2021-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.